Galera Therapeutics Inc. (GRTX)
OTC: GRTX
· Real-Time Price · USD
0.03
0.00 (9.09%)
At close: Apr 04, 2025, 2:24 PM
Galera Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.18 | -0.42 | -0.52 | -0.35 | -0.13 | -1.62 | -1.27 | -0.64 | -0.61 | -0.51 | -0.9 | -1.81 | -2.35 | -2.79 | -2.94 |
PEG Ratio | -0.01 | 0.06 | 0.03 | 0.01 | 0.00 | 0.40 | 0.09 | 0.04 | -0.06 | 0.17 | -0.29 | 0.07 | 1.04 | -0.16 | 0.47 |
PS Ratio | n/a | n/a | n/a | 89.86 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -0.03 | -0.05 | -0.07 | -0.06 | -0.06 | -1.16 | -0.92 | -0.38 | -0.48 | -0.42 | -0.9 | -2.09 | -4.94 | -9.79 | -20.85 |
P/FCF Ratio | 0.52 | -2.5 | -1.89 | -0.8 | -0.64 | -12.4 | -7.72 | -2.99 | -5.06 | -3.92 | -5.59 | -6.94 | -11.56 | -14.84 | -14.23 |
P/OCF Ratio | 0.52 | -2.5 | -1.89 | -0.8 | -0.64 | -12.46 | -7.72 | -2.99 | -5.07 | -3.92 | -5.59 | -6.96 | -11.58 | -14.86 | -14.4 |
OCF/S Ratio | n/a | n/a | n/a | -112.67 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | -0.01 | -1.13 | -1.16 | -0.01 | -0.01 | n/a | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.02 | -0.05 |
Quick Ratio | 9.74 | 5.63 | 7.54 | 4.36 | 2.47 | 3.08 | 4.09 | 2.88 | 3.86 | 5.02 | 5.97 | 5.98 | 5.89 | 6.46 | 4.05 |
Current Ratio | 9.74 | 5.63 | 7.54 | 4.36 | 2.47 | 3.08 | 4.09 | 2.88 | 3.86 | 5.02 | 5.97 | 5.98 | 5.89 | 6.46 | 4.05 |
Asset Turnover | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -7.34 | -6.42 | -3.82 | -3.29 | -3.96 | -3.99 | -4.43 | -5.71 | -6.27 | -8.72 | -16.2 | -13.95 |
Return on Equity | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Invested Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | -1.44 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | -63.49 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | -63.49 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | -58.82 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | -56.38 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |